S

State of Wisconsin Investment Board

Manages public funds through investment portfolio

Private Debt and Equity Intern

Summer 2027
No salary listed
Internship
Bachelor's
Madison, WI, USA
In PersonMust work in Madison, Wisconsin, for approximately 10 weeks beginning in late May or early June 2027.
Finance & BankingPrivate Equity

About the job

Requirements
  • Ability to work in Madison, Wisconsin, for an approximate 10-week period beginning in late May or early June 2027.
  • Be an undergraduate or graduate student majoring in Finance or Accounting.
  • Have relevant coursework in accounting and a basic understanding of financial statement analysis.
  • Be proficient in Microsoft Office Suite, especially Excel.
  • Be familiar with artificial intelligence tools, especially ChatGPT and Microsoft Copilot.
  • Have excellent written and verbal communication skills.
Responsibilities
  • Spread financial statements, review recent operating results, and analyze the performance of existing private debt investments.
  • Assist Portfolio Managers and Investment Analysts with the due diligence process on private equity funds and co-investments through quantitative and qualitative methods, resulting in an investment recommendation.
  • Perform fundamental credit analysis on prospective new private debt investments.
  • Complete special projects as assigned.
Desired Qualifications
  • Financial modeling experience is a plus.

About the company

S

State of Wisconsin Investment Board

View

SWIB manages and invests Wisconsin’s public employee retirement funds and other state assets for residents. It pursues long-term investments across stocks, bonds, real assets, and alternatives using internal research, risk controls, and external managers to build diversified portfolios and meet actuarial targets while controlling costs. As a state agency, it operates with fiduciary responsibility to public funds, emphasizing prudent stewardship, transparency, and long-horizon investing at scale. Its goal is to maximize long-term returns for Wisconsin’s public retirement systems while keeping risk and costs in check to ensure stable funding for beneficiaries.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

Madison, Wisconsin

Founded

1951

Get referred to State of Wisconsin Investment Board

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SWIB reported $3.8B in five-year outperformance on March 20, 2026.
  • January 21, 2026 preliminary 2025 results reinforced strong pension-fund performance.
  • June 2026 private-market commitments added $3.5B across equity, debt, and real estate.

What critics are saying

  • Private-market marks and exits drive 2026 returns, leaving SWIB exposed through 2027.
  • A downturn in Wisconsin politics can reshape trustees, compensation, and hiring quickly.
  • Persistent underperformance would trigger benefit-pressure headlines and damage SWIB’s recruiting edge.

What makes State of Wisconsin Investment Board unique

  • SWIB manages $178B for Wisconsin pensions with deep internal investment teams.
  • In 2026, SWIB marked 75 years and $3.8B above benchmarks.
  • SWIB’s private-equity, debt, and real-estate program spans $27B-plus.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Comprehensive benefits package
  • Educational and training opportunities
  • Tuition reimbursement
  • Hybrid work environment
  • Relocation Assistance
  • Professional Development Budget
  • Hybrid Work Options

Company News

PR Newswire
Nov 6th, 2025
Elephas Biosciences Raises $40M for Platform

Elephas Biosciences raised $40M in a Series B-2 funding round to accelerate the commercialization of its Elephas Live™ Platform, a live tumor profiling technology for predicting immunotherapy responses. The funding, supported by existing investors like Northpond Ventures and ARCH Venture Partners, will aid in launching the platform as a laboratory developed test in 2026. CEO Maneesh Arora highlighted the strong investor confidence and the company's progress towards improving cancer treatment.

PR Newswire
Jan 23rd, 2024
Elephas Announces $55 Million In Series C Funding

Company advancing novel live tumor imaging diagnostic platformMADISON, Wis., Jan. 23, 2024 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $55 million in Series C funding. Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB) led the round. Continuing investments were made by Northpond Ventures, ARCH Ventures, Sands Capital, Moore Strategic Ventures, Tao Invest, and WARF Ventures. With this $55 million Series C funding, this brings the total raised by Elephas to $116.5 million.Elephas is developing an oncology imaging diagnostics platform to predict response to immunotherapy using the latest advances in metabolic imaging. The platform utilizes live patient biopsies with intact native tumor architecture and treats them with potential therapies to predict response to treatment

PR Newswire
Dec 13th, 2022
HistoSonics Announces $100 Million in Financings and New Appointment to its Board of Directors

/PRNewswire/ -- HistoSonics, Inc. (www.histosonics.com), the developer of a non-invasive, novel sonic beam therapy, announced today that it has raised $85...